Literature DB >> 670962

Papilledema following therapeutic dosages of lithium carbonate.

A Lobo, E Pilek, P E Stokes.   

Abstract

A patient with diagnosis of manic-depressive illness, circular type, and receiving therapeutic dosages of lithium carbonate, developed papilledema that seemed to be directly related to the drug. Although this is an extremely rare complication, the authors suggest that fundal exams may be considered in patients treated with lithium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670962     DOI: 10.1097/00005053-197807000-00009

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Optic nerve dysfunction secondary to long-term use of lithium carbonate.

Authors:  Seiichiro Fujii; Hidehiro Oku; Rieko Takahashi; Yuko Kanbara; Jun Sugasawa; Tsunehiko Ikeda
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

Review 2.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 3.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.